Cash-strapped Viva Biotech sells stake and plans spinoff
The biotech has gained a capital injection from Temasek and a major Chinese investor, but the deal has not boosted investor confidence Key Takeaways： As well as tapping strategic investors,…
Recent Articles
RECENT ARTICLES
-
After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
2696.HK - Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
CIFI restructuring advances as shareholders face massive dilution
0884.HK
-
BRIEF: Bossini privatization approved, to delist in mid-March
0592.HK 0933.HK 2331.HK
-
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
ZYBT.US
-
Innovent ditches low-value stake sale after investor outcry
1801.HK
